| 2-AG | 2-Arachidonoylglycerol |
| AEA | Anandamide |
| ANOVA | Analysis of variance |
| BCRP | Breast cancer resistance protein |
| CBD | Cannabidiol |
| CBG | Cannabigerol |
| CER[NDS] | Ceramides containing non-hydroxy fatty acids and dihydrosphingosine |
| CER[NS] | Ceramides containing non-hydroxy fatty acids and sphingosine |
| COX-2 | Cyclooxygenase-2 |
| CRAC | Calcium-release-activated calcium channel |
| DPH | 1,6-Diphenyl-1,3,5-hexatriene |
| HDF | Human skin fibroblasts |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| Kv1.3 | Potassium channel |
| LDH | Lactate dehydrogenase |
| MAPK | Mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MDR1 | Multidrug resistance protein 1 |
| MRP | Multidrug-resistance-associated proteins |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NHEK | Normal human epidermal keratinocytes |
| factors Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| PC | Phosphatidylcholine |
| PI | Phosphatidylinositol |
| (PI3K)/AKT | Phosphatidylinositol 3-phosphatidyl kinase |
| PS | Phosphatidylserine |
| ROS | Reactive oxygen species |
| SM | Sphingomyelin |
| TMA-DPH | N,N,N-Trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl)phenylammonium p-Toluenesulfonate |
| TNF-α | Tumor necrosis factor alpha |
| TNFR | Tumor necrosis factor receptor |
| UVA | Ultraviolet A |